File(s) not publicly available
Atypical hearing loss in women with breast cancer receiving adjuvant treatment
journal contribution
posted on 2023-06-08, 11:18 authored by Valerie JenkinsValerie Jenkins, H Beveridge, R Low, S MitraThere are no reports of adjuvant treatments for early breast cancer causing hearing loss. Yet in this exploratory study 14/16 women who had received Fluorouracil, Epirubicin and Cyclophosphamide (FEC) chemotherapy regimen, 11 of whom also received endocrine treatment, had reduced hearing sensitivity, with 9/16 being atypical. It is not clear whether this finding is related to oestrogen reduction and/or ototoxicity but a more detailed investigation in this area is warranted given the large number of women with breast cancer who receive adjuvant treatments.
History
Publication status
- Published
Journal
BreastISSN
0960-9776Publisher
ElsevierExternal DOI
Issue
3Volume
15Page range
448-51Department affiliated with
- Sussex Health Outcomes Research & Education in Cancer (SHORE-C) Publications
Notes
Journal Article Research Support, Non-U.S. Gov't ScotlandFull text available
- No
Peer reviewed?
- Yes